| Literature DB >> 22900893 |
Guangfang Guo1, Dongwen Lv, Xing Yan, Saminathan Subburaj, Pei Ge, Xiaohui Li, Yingkao Hu, Yueming Yan.
Abstract
BACKGROUND: The analyses of protein synthesis, accumulation and regulation during grain development in wheat are more complex because of its larger genome size compared to model plants such as Arabidopsis and rice. In this study, grains from two wheat cultivars Jimai 20 and Zhoumai 16 with different gluten quality properties were harvested at five development stages, and were used to displayed variable expression patterns of grain proteins.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22900893 PMCID: PMC3480910 DOI: 10.1186/1471-2229-12-147
Source DB: PubMed Journal: BMC Plant Biol ISSN: 1471-2229 Impact factor: 4.215
Figure 1Grain development during five stages (I, II, III, IV and V) in wheat cultivars Jimai 20 and Zhoumai 16. A. Grain morphological development (the red lines represent 2 mm). B. Grain weight accumulation. C. SEM images of transverse grain sections at five developmental stages. Red lines represent 15 μm. A and B type starch granules are indicated.
Figure 22-DE maps of proteins extracted from the first sample of Jimai 20.
Figure 3Zhoumai 16 at five stages of grain development.
Differentially expressed proteins identified by MALDI-TOF/TOF-MS at five grain developmental stages in bread wheat cultivars Jimai 20 and Zhoumai 16
| 22 | gi/49343245 | Cytosolic malate dehydrogenase | 100 | 161 | 6 | 5.36/5.75 | 1:1.1:2.4:1.3:0.3 | 0.015 | 1:1.2:0.8:0.3:0.2 | 0.036 | C/C | Cyto | |
| 23 | gi/49343245 | Cytosolic malate dehydrogenase | 100 | 51 | 2 | 5.76/5.75 | 1:1.5:2.6:1.4:0.4 | 0.023 | 1:1.4:1.0:0.4:0.3 | 0.030 | C/C | Cyto | |
| 24 | gi/37928995 | Cytosolic malate dehydrogenase | 100 | 266 | 3 | 5.98/6.62 | 1:0.7:.0.4:0.3:0 | 0.038 | 1:0.7:0.6:0:0 | 0.027 | A/A | Cyto | |
| 25 | gi/15232820 | MDH (malate dehydrogenase) | 100 | 101 | 2 | 6.82/8.66 | 1:0.8:0.8:0.5:0.3 | 0.019 | 1:0.7:1.0:0.7:0.4 | 0.019 | A/A | P | |
| 32 | gi/7488742 | Isocitrate dehydrogenase (NADP) precursor | 99 | 144 | 3 | 5.54/6.15 | 1:0.6:0.7:0.5:0.1 | 0.041 | 1:0.9:0.5:0.4:0.2 | 0.011 | A/A | P | |
| 33 | gi/92875135 | Isocitrate dehydrogenase NADP-dependent | 97.38 | 98 | 2 | 6.02/5.99 | 1:0.8:0.5:0.3:0.3 | 0.021 | 1:0.5:0.5:0.2:0.2 | 0.018 | A/A | Mito | |
| 1 | gi/32400802 | Phosphoglycerate mutase | 100 | 71 | 2 | 5.55/5.43 | 1:0.4:0.4:0.2:0.1 | 0.032 | 1:0.5:0.3:0.2:0 | 0.029 | A/A | Cyto | |
| 2 | gi/32400802 | Phosphoglycerate mutase | 100 | 55 | 2 | 5.45/5.43 | 1:0.7:0.5:0.3:0.2 | 0.017 | 1:0.6:0.6:0.5:0.3 | 0.034 | A/A | Cyto | |
| 4 | gi/120680 | Glyceraldehyde-3-phosphate dehydrogenase, cytosolic | 100 | 323 | 4 | 6.46/6.67 | 1:1.4:0.9:0.4:0.2 | 0.025 | 1:1.0:0.3:0.3:0.1 | 0.015 | C/A | Cyto | |
| 5 | gi/120680 | Glyceraldehyde-3-phosphate dehydrogenase, cytosolic | 100 | 430 | 4 | 6.67/6.67 | 1:1.2:0.9:0.5:0.4 | 0.014 | 1:1.5:0.8:0.5:1.1 | 0.014 | C/C | Cyto | |
| 6 | gi/120668 | Glyceraldehyde-3-phosphate dehydrogenase, cytosolic | 100 | 317 | 4 | 6.43/6.20 | 1:2.1:0.5:0.8:0.9 | 0.024 | 1:1.9:1.0:0.5:0.6 | 0.022 | C/C | Cyto | |
| 7 | gi/148508784 | Glyceraldehyde-3-phosphate dehydrogenase | 100 | 99 | 4 | 6.44/7.08 | 1:1.6:0.6:0.5:0.2 | 0.026 | 1:1.2:0.4:0.4:0.1 | 0.011 | C/C | Cyto | |
| 8 | gi/148508784 | Glyceraldehyde-3-phosphate dehydrogenase | 100 | 137 | 4 | 7.47/7.08 | 1:1.3:0.4:0.4:0.3 | 0.031 | - | - | C/- | Cyto | |
| 9 | gi/148508784 | Glyceraldehyde-3-phosphate dehydrogenase | 100 | 126 | 2 | 7.36/7.08 | 1:1.4:3.2:5.8:0.2 | 0.037 | 1:1.3:6.2:3.2:2.4 | 0.030 | C/C | Cyto | |
| 11 | gi/18978 | Glyceraldehyde 3-phosphate dehydrogenase | 99.83 | 351 | 4 | 6.82/6.67 | 1:1.3:1:0.6:0.2 | 0.011 | 1:0.9:1.7:1.1:0.1 | 0.010 | C/C | Cyto | |
| 12 | gi/18978 | Glyceraldehyde 3-phosphate dehydrogenase | 100 | 131 | 1 | 7.23/6.67 | 1:0.8:0.5:0.2:0 | 0.029 | 1:0.5:0.2:0:0 | 0.024 | A/A | Cyto | |
| 13 | gi/7579064 | Cytosolic glyceraldehyde-3- phosphate | 100 | 238 | 3 | 6.16/7.83 | 0:0:0:1:1.3 | 0.041 | 0:0:0:1.0:1.9 | 0.011 | B/B | Cyto | |
| 14 | gi/32478662 | Cytosolic glyceraldehyde-3- phosphate | 100 | 208 | 2 | 6.66/6.34 | 1:1.2:0.8:0.6:0.3 | 0.005 | 1:1.4:0.8:0.5:0.5 | 0.023 | C/C | Cyto | |
| 16 | gi/28172909 | Cytosolic 3-phosphoglycerate kinase | 100 | 52 | 2 | 4.76/4.91 | 1:1.6:2.1:1.7:0.4 | 0.019 | 1:1.9:1.6:2.0:0.6 | 0.035 | C/C | Cyto | |
| 18 | gi/18076790 | Phosphoglucomutase (PGM) | 100 | 73 | 2 | 5.84/5.66 | 1:1.3:2.3:0.9:0.8 | 0.017 | 1:1.7:3.9:0.6:0.4 | 0.029 | C/C | Cyto | |
| 19 | gi/18076790 | Phosphoglucomutase (PGM) | 98.67 | 47 | 1 | 5.85/5.66 | 1:0.7:0.2:0:0 | 0.026 | 1:0.5:0.2:0:0 | 0.015 | A/A | Cyto | |
| 20 | gi/226316441 | Fructose-bisphosphate aldolase | 100 | 64 | 2 | 6.33/6.85 | 0:0:1.0:3.1:3.0 | 0.023 | 0:0:1.0:4.1:4.7 | 0.016 | B/B | Cyto | |
| 21 | gi/18496065 | Putative fructose 1-,6-biphosphate aldolase | 98.12 | 84 | 1 | 6.15/8.71 | 1:0.5:0.2:0:0 | 0.034 | 1:0.4:0.2:0:0 | 0.034 | A/A | Cyto | |
| 26 | gi/1785948 | Cytosolic triosephosphate isomerase | 100 | 148 | 2 | 5.18/5.39 | 1:1.1:0.7:0.5:1.4 | 0.036 | 1:2.1:1.6:2.0:1.7 | 0.025 | E/E | Cyto | |
| 27 | gi/11124572 | Triosephosphat-isomerase | 100 | 116 | 2 | 4.46/5.38 | 1:1.4:0.6:0:0 | 0.013 | 1:0.8:0.4:0:0 | 0.022 | C/A | Cyto | |
| 29 | gi/11124572 | Triosephosphat-isomerase | 100 | 235 | 3 | 5.72/5.38 | 1:1.4:0.8:0.5:0.2 | 0.012 | 1:0.9:0.5:0.3:0 | 0.037 | C/A | Cyto | |
| 37 | gi/133872550 | Bp2A protein | 100 | 132 | 3 | 5.38/5.86 | 1:1.5:1:0.7:0.2 | 0.022 | 1:0.8:0.6:0.5:0 | 0.033 | C/A | Cyto | |
| 38 | gi/32400847 | Formate dehydrogenase | 100 | 68 | 2 | 6.02/8.61 | 0:0:1.0:2.6:2.9 | 0.033 | 0:0:0:1.0:1.5 | 0.019 | B/B | Cyto | |
| 39 | gi/32400847 | Formate dehydrogenase | 100 | 112 | 3 | 6.45/8.61 | 0:0:1.0:3.4:6.1 | 0.031 | 0:0:1.0:3.2:7.8 | 0.028 | B/B | Cyto | |
| 35 | gi/21680 | ADP-glucose pyrophosophorylase preprotein | 95.78 | 54 | 2 | 6.35/6.61 | 1:0.8:0.7:0.6:0.4 | 0.027 | 1:0.8:0.6:0.6:0.3 | 0.027 | A/A | P | |
| 41 | Q0PG36 | Glucose-1-phosphate adenylyltransferase | 100 | 183 | 5 | 6.02/6.12 | 1:1.3:0.4:0.2:0.2 | 0.029 | 1:1.2:0.4:0.2:0.1 | 0.034 | C/C | P | |
| 44 | Q0PG36 | Glucose-1-phosphate adenylyltransferase | 100 | 110 | 3 | 6.42/6.12 | 1:0.9:0.6:0.4:0.2 | 0.021 | 1:1.5:0.8:0.4:0.3 | 0.024 | A/C | P | |
| 45 | Q0PG36 | Glucose-1-phosphate adenylyltransferase | 100 | 125 | 3 | 6.23/5.89 | 1:0.8:0.5:0.2:0.1 | 0.037 | 1:1.3:0.6:0.3:0.2 | 0.016 | A/C | P | |
| 30 | gi/167113 | Aldose reductase-related protein | 98.12 | 101 | 1 | 6.19/6.28 | 0:0:0:1.0:1.8 | 0.034 | 0:0:0:1.0:6.8 | 0.025 | B/B | Cyto | |
| 31 | gi/167113 | Aldose reductase-related protein | 99.83 | 116 | 2 | 6.17/6.28 | 0:0:0:1.0:0.8 | 0.036 | 0:0:1.0:1.8:1.5 | 0.028 | C/C | Cyto | |
| 40 | gi/218157 | Cytoplasmic aldolase | 100 | 110 | 2 | 6.65/6.56 | 1:0.6:0.3:0.2:0.1 | 0.031 | 1:0.9:0.4:0.3:0.1 | 0.019 | A/A | Cyto | |
| 145 | gi/66840998 | 5a2 protein | 100 | 187 | 4 | 5.84/8.38 | 1:8.3:3.5:2.1:2.4 | 0.038 | 1:1.1:0.5:0.7:0.7 | 0.024 | C/C | P | |
| 36 | gi/41052632 | Peptidylprolyl isomerase Cyp2 | 96.38 | 50 | 2 | 8.97/8.61 | 1:0.2:0.8:0.9:1.1 | 0.012 | 1:0.5:0.5:0.4:0.8 | 0.014 | D/D | Cyto | |
| 54 | gi/154761388 | Cyclophilin | 98.21 | 19 | 2 | 8.39/8.59 | 1:0.3:1.3:1.4:1.6 | 0.027 | 1:0.5:0.4:0.4:0.8 | 0.011 | D/D | Cyto | |
| 55 | gi/154761388 | Cyclophilin | 100 | 84 | 3 | 9.12/8.59 | 1:0.2:0.8:0.9:1.1 | 0.031 | 1:0.6:0.5:0.5:0.9 | 0.009 | D/D | Cyto | |
| 56 | gi/154761388 | Cyclophilin | 100 | 95 | 3 | 6.28/8.59 | 0:0:0:1.0:6.8 | 0.013 | - | - | B/- | Cyto | |
| 59 | gi/32352154 | Nascent polypeptide associated complex alpha chain | 100 | 83 | 1 | 4.17/4.34 | 0:0:0:1.0:2.1 | 0.016 | 0:0:0:1.0:3.0 | 0.028 | B/B | Cyto | |
| 62 | gi/2492077 | Sequence 5 from patent US 5668007 | 100 | 189 | 2 | 6.68/6.77 | 0:1.0:3.5:2.1:5.3 | 0.027 | 0:1.0:0.9:3.0:6.7 | 0.017 | B/B | Cyto | |
| 106 | gi/75279909 | Serpin-Z2B; AltName: Full = TriaeZ2b; | 100 | 213 | 4 | 5.24/5.18 | 0:0:0:1.0:0.6 | 0.021 | 0:0:1.0:1.7:0.5 | 0.016 | C/C | P | |
| 107 | gi/75279909 | Serpin-Z2B; AltName: Full = TriaeZ2b; | 100 | 256 | 4 | 5.32/5.18 | 1:1.8:2.4:1.4:0.9 | 0.023 | 0:0:1.0:1.7:1.4 | 0.021 | C/C | P | |
| 128 | gi/12229936 | Proteasome subunit alpha type 7 (20S proteasome alpha subunit D) | 100 | 110 | 2 | 12.10/6.86 | 1:1.1:5.1:5.9:8.3 | 0.032 | 1:1.3:3.2:3.9:6.3 | 0.033 | B/B | P | |
| 67 | gi/171027826 | Triticin | 100 | 84 | 2 | 8.94/6.43 | 0:0:1.0:1.4:3.0 | 0.042 | 0:0:1.0:2.0:3.3 | 0.045 | B/B | ER | |
| 68 | gi/171027826 | Triticin | 100 | 475 | 6 | 6.35/6.43 | 0:0:1.0:2.1:5.5 | 0.039 | 0:0:1.0:2.4:6.5 | 0.041 | B/B | ER | |
| 69 | gi/7548844 | Triticin precursor | 99.92 | 169 | 3 | 6.05/9.37 | 1:0.8:0.5:0.6:0.4 | 0.026 | 1:0.4:0.5:0.4:0.3 | 0.038 | A/A | ER | |
| 70 | gi/215398470 | Globulin 3 | 100 | 471 | 5 | 7.24/7.78 | 0:0:0:1.0:2.6 | 0.019 | 0:0:0:1.0:2.0 | 0.008 | B/B | ER | |
| 71 | gi/215398470 | Globulin 3 | 100 | 148 | 5 | 7.43/7.78 | 0:0:0:1.0:6.1 | 0.025 | 0:0:0:1.0:3.9 | 0.010 | B/B | ER | |
| 72 | gi/89143122 | Putative avenin-like b precursor | 100 | 166 | 3 | 6.88/8.08 | 0:0:1.0:3.3:2.1 | 0.010 | 1.0:1.7:6.5:2.9:5. | 0.034 | C/C | ER | |
| 73 | gi/145321072 | Avenin-like protein | 100 | 97 | 2 | 6.63/8.29 | 0:0:1.0:3.2:4.1 | 0.024 | 0:0:1.0:3.5:4.0 | 0.031 | B/B | ER | |
| 74 | gi/209971847 | Gamma-gliadin | 99.92 | 70 | 1 | 6.84/7.55 | 0:0:1.0:2.0:4.8 | 0.029 | 1.0:1.7:6.5:9.4:12.8 | 0.028 | B/B | ER | |
| 75 | gi/133741924 | Gamma gliadin | 100 | 93 | 2 | 5.33/8.88 | 1:2.5:4.2:9.9:11.9 | 0.020 | 1:2.2:3.9:5.9:6.4 | 0.022 | B/B | ER | |
| 76 | gi/133741924 | Gamma gliadin | 98.12 | 52 | 2 | 5.56/8.88 | 0:1:2.9:3.8:4.7 | 0.034 | 0:0:1.0:1.4:2.2 | 0.036 | B/B | ER | |
| 77 | gi/209971907 | Gamma-gliadin | 97.35 | 55 | 2 | 8.55/8.64 | 0:1:2.0:2.2:4.2 | 0.031 | 0:0:1.0:1.6:2.1 | 0.031 | B/B | ER | |
| 78 | gi/164470668 | LMW-s glutenin subunit 0359D24-S | 99.83 | 60 | 2 | 8.40/8.48 | 0:0:1:3.6:5.0 | 0.027 | 0:0:0:1.0:1.2 | 0.030 | B/B | ER | |
| 79 | gi/47607146 | S-type low molecular weight glutenin L4-55 | 100 | 90 | 2 | 8.67/8.51 | 0:0:0:1.0:2.9 | 0.024 | - | - | B/- | Cyto | |
| 80 | gi/215398468 | Globulin 3C | 100 | 80 | 2 | 6.37/9.15 | 0:0:0:1.0:1.6 | 0.026 | 0:0:0:1.0:2.0 | 0.041 | B/B | ER | |
| 81 | gi/421978 | Globulin Beg1 precursor | 100 | 85 | 2 | 5.64/6.81 | 0:0:0:1.0:4.2 | 0.031 | 0:0:0:1.0:3.0 | 0.044 | B/B | ER | |
| 82 | gi/167004 | Embryo globulin | 95.67 | 53 | 1 | 6.79/6.81 | 0:0:0:1.0:4.4 | 0.011 | 0:0:0:1.0:2.5 | 0.025 | B/B | ER | |
| 84 | gi/170696 | Storage protein | 100 | 52 | 1 | 9.49/6.82 | 0:0:1.0:1.4:1.7 | 0.012 | 0:0:1.0:0.8:2.0 | 0.018 | B/B | ER | |
| 47 | gi/164471780 | Aspartate aminotransferase | 99.96 | 25 | 2 | 6.61/6.77 | 1:1.3:1.0:0.6:0.1 | 0.019 | 1:0.9:0.8:0.6:0.2 | 0.027 | C/A | Cyto | |
| 48 | gi/164471780 | Aspartate aminotransferase | 100 | 25 | 2 | 6.95/6.77 | 1:0.8:0.5:0.2:0.3 | 0.021 | 1:0.6:0.5:0.2:0.2 | 0.024 | A/A | Cyto | |
| 49 | gi/584706 | Aspartate aminotransferase, cytoplasmic | 100 | 159 | 3 | 6.89/7.75 | - | - | 1:0.7:0.5:0:0 | 0.031 | -/A | Cyto | |
| 51 | gi/14018051 | Putative alanine aminotransferase | 100 | 107 | 3 | 6.11/6.23 | 1:2.4:3.3:2.6:1.5 | 0.034 | 1:3.4:2.1:2.1:1.1 | 0.034 | C/C | Cyto | |
| 52 | gi/56315117 | Predicted serine-pyruvate aminotransferase | 100 | 113 | 1 | 6.18/5.86 | 0:0:0:1.0:2.7 | 0.031 | 0:0:0:1.0:1.7 | 0.018 | B/B | Cyto | |
| 53 | gi/6006863 | Putative methionine synthase | 98.76 | 69 | 1 | 5.88/6.09 | 1:2.4:3.3:2.6:1.5 | 0.030 | 1:0.7:0.5:0:0 | 0.016 | C/A | Cyto | |
| 60 | gi/479830 | Translation elongation factor eEF-1 beta' chain | 100 | 64 | 1 | 4.63/4.54 | 0:0:0:1.0:2.2 | 0.016 | 0:0:0:1.0:1.7 | 0.028 | B/B | Cyto | |
| 85 | gi/18419557 | Transposase | 97.54 | 98 | 4 | 6.53/9.48 | 1:1.8:6.1:1.6:0.2 | 0.015 | 1:1.5:2.2:1.7:1.1 | 0.027 | C/C | Nucl | |
| 86 | gi/30793446 | 27 K protein | 98.12 | 71 | 1 | 6.01/6.06 | - | - | 1:1.9:2.6:2.7:3.3 | 0.035 | -/B | Cyto | |
| 87 | gi/30793446 | 27 K protein | 95.89 | 69 | 1 | 5.98/6.06 | 0:0:0:1.0:2.1 | 0.045 | 0:0:0:1.0:2.3 | 0.031 | B/B | Cyto | |
| 88 | gi/30793446 | 27 K protein | 100 | 171 | 4 | 5.64/6.06 | 1:1.9:2.0:3.6:3.4 | 0.025 | 1:1.1:2.1:1.6:2.0 | 0.012 | B/E | Cyto | |
| 89 | gi/46394372 | TPA: TPA_inf: WRKY transcription factor 59 | 95.45 | 113 | 2 | 5.46/7.7 | 1:1.4:2.2:3.0:2.9 | 0.018 | 1:1.8:2.2:4.4:2.7 | 0.028 | B/C | P | |
| 90 | gi/30793446 | 27 K protein | 100 | 60 | 1 | 6.06/6.06 | 0:0:0:1.0:2.3 | 0.021 | 0:0:0:1.0:2.2 | 0.015 | B/B | Cyto | |
| 91 | gi/27735373 | Replication factor C like protein | 100 | 64 | 1 | 5.84/8.92 | 1:0.5:0.3:0.2:0.2 | 0.026 | 1:1.4:0.8:0.7:0.5 | 0.024 | A/C | Nucl | |
| 93 | Q03033 | Elongation factor 1-alpha | 100 | 97 | 2 | 9.35/9.20 | 0:0:0:1.0:2.1 | 0.034 | 0:0:0:1.0:2.6 | 0.026 | B/B | Nucl | |
| 64 | gi/134290443 | Pm3b-like disease r esistance protein 15Q1 | 96.58 | 96 | 2 | 7.21/6.27 | 1:1.3:0.40.4:0.3 | 0.029 | 1:1.0:0.4:0.3:0.4 | 0.024 | C/A | Cyto | |
| 65 | gi/18145 | Putative protein has homology to G protein | 100 | 60 | 1 | 5.89/7.59 | 0:1.0:3.2:1.6:0 | 0.042 | 1:1.0:1.6:1.2:0 | 0.026 | C/C | Cyto | |
| 66 | gi/50932677 | Putative guanine nucleotide- binding protein | 100 | 121 | 2 | 6.07/6.06 | 0:1.0:2.7:1.4:0 | 0.044 | 1:1.1:3.4:2.2:0.8 | 0.034 | C/C | Cyto | |
| 142 | gi/9652119 | Nucleoside diphosphate kinase | 99.92 | 192 | 2 | 6.36/6.30 | 1:0.9:0.7:0.4:0.2 | 0.019 | 1:0.8:0.8:0.5:0.2 | 0.021 | A/A | Cyto | |
| 57 | gi/640015 | CMx | 100 | 102 | 2 | 5.51/9.23 | 0:0:1.0:2.5:1.8 | 0.036 | 0:0:1.0:2.8:2.4 | 0.022 | C/C | P | |
| 58 | gi/75107149 | RecName: Full = Chymotrypsin inhibitor WCI; AltName: Full = Chloroform/ methanol-soluble | 100 | 164 | 3 | 7.34/7.42 | 0:0:1.0:3.3:1.9 | 0.027 | 0:0:1.0:2.7:0.9 | 0.015 | C/C | Cyto | |
| 94 | gi/38098487 | Alpha amylase inhibitor protein | 99.91 | 62 | 2 | 6.65/7.44 | 0:0:1.0:3.4:4.0 | 0.021 | 0:0:1.0:3.0:3.5 | 0.018 | B/B | P | |
| 95 | gi/66841026 | Alpha-amylase inhibitor 0.19 | 100 | 94 | 2 | 7.72/6.86 | 0:0:1.0:2.0:1.2 | 0.031 | 0:0:1.0:2.7:2.0 | 0.024 | C/C | P | |
| 96 | gi/66841026 | Alpha-amylase inhibitor 0.19 | 100 | 493 | 5 | 6.98/6.86 | 0:0:1.0:4.3:5.0 | 0.021 | 0:1.0:1.7:3.9:2.7 | 0.038 | B/C | P | |
| 97 | gi/123956 | Alpha-amylase/trypsin inhibitor CM2; | 100 | 191 | 2 | 5.71/6.86 | 0:0:1.0:2.2:1.2 | 0.018 | 0:1.0:1.4:3.5:1.1 | 0.016 | C/C | Extr | |
| 98 | gi/221855644 | Alpha-amylase inhibitor CM16 subunit | 99.96 | 60 | 2 | 4.56/5.31 | 0:0:1.0:4.2:1.4 | 0.021 | 0:0:1.0:2.3:1.7 | 0.035 | C/C | Extr | |
| 99 | gi/221855644 | Alpha-amylase inhibitor CM16 subunit | 100 | 97 | 2 | 5.11/5.31 | 0:0:1.0:3.1:1.6 | 0.024 | 0:1.0:2.5:5.4:3.2 | 0.026 | C/C | Extr | |
| 100 | gi/225042 | Alpha amylase inhibitor | 100 | 64 | 2 | 6.65/6.77 | 1:2.7:9.4:5.5:13.9 | 0.029 | 1:4.1:10.4:6.1:13.1 | 0.036 | E/E | Cyto | |
| 101 | gi/123955 | Alpha-amylase/trypsin i nhibitor CM1; | 100 | 73 | 2 | 6.81/7.49 | 0:0:1.0:3.1:3.0 | 0.012 | 1:1.0:1.4:4.1:3.3 | 0.012 | B/C | Extr | |
| 102 | gi/54778507 | 0.19 dimeric alpha-amylase inhibitor | 100 | 238 | 2 | 6.76/5.73 | 1:1.5:2.6:2.4:2.3 | 0.025 | 1:1.6:2.1:2.7:2.4 | 0.028 | C/C | P | |
| 104 | gi/408873 | Puroindoline = basic cystine-rich protein | 100 | 125 | 4 | 9.05/5.60 | 1:1.5:2.8:2.9:2.6 | 0.016 | 1:1.2:1.7:4.0:1.4 | 0.023 | C/C | P | |
| 105 | gi/408873 | Puroindoline = basic cystine-rich protein | 100 | 125 | 4 | 6.73/8.76 | 0:0:1.0:3.0:5.2 | 0.039 | 0:0:1.0:2.0:2.5 | 0.045 | B/B | P | |
| 110 | gi/51247633 | Chain A, Crystal Structure Of Family 11 | 100 | 78 | 2 | 8.24/5.18 | 0:0:1.0:0.9:3.1 | 0.038 | 0:0:1.0:3.2:7.2 | 0.008 | B/B | P | |
| 111 | gi/51247633 | Chain A, Crystal Structure Of Family 11 | 100 | 163 | 3 | 8.32/5.18 | 0:0:1.0:1.4:1.5 | 0.027 | 0:0:1.0:4.5:5.8 | 0.015 | B/B | P | |
| 112 | gi/62465514 | Class II chitinase | 100 | 95 | 2 | 8.39/5.56 | 0:0:1.0:1.1:1.8 | 0.025 | 0:0:1.0:0.7:1.7 | 0.028 | B/B | Extr | |
| 113 | gi/62465514 | Class II chitinase | 100 | 54 | 1 | 8.42/8.27 | 0:0:1.0:1.1:1.6 | 0.024 | 0:0:1.0:1.2:2.0 | 0.015 | B/B | Extr | |
| 114 | gi/62465514 | Class II chitinase | 100 | 138 | 2 | 8.37/8.27 | 1:2.5:5.8:3.0:9.8 | 0.025 | 1:1.2:2.1:2.1:6.2 | 0.025 | B/B | Extr | |
| 115 | gi/62465514 | Class II chitinase | 100 | 69 | 3 | 8.35/8.27 | 0:0:1.0:1.2:1.9 | 0.038 | 0:0:1.0:0.8:3.9 | 0.005 | B/B | Extr | |
| 116 | gi/62465514 | Class II chitinase | 100 | 206 | 4 | 7.40/8.66 | 0:0:1.0:1.4:1.5 | 0.027 | 0:0:1.0:1.6:2.1 | 0.034 | B/B | Extr | |
| 117 | gi/25989705 | LEA1 protein | 100 | 117 | 2 | 9.21/8.81 | 0:0:0:1.0:2.9 | 0.012 | 0:0:0:1.0:2.7 | 0.021 | B/B | Nucl | |
| 119 | gi/134034615 | Monomeric alpha-amylase inhibitor | 99.98 | 45 | 2 | 5.54/5.37 | 0:0:0:1.0:2.0 | 0.019 | 0:0:0:1.0:1.6 | 0.025 | B/B | P | |
| 120 | gi/134034615 | Monomeric alpha-amylase inhibitor | 100 | 47 | 2 | 5.65/5.37 | - | - | 0:1.0:1.6:2.1:2.7 | 0.015 | -/B | P | |
| 121 | gi/22001285 | Peroxidase 1 | 99.99 | 58 | 3 | 7.35/8.14 | 1:1.3:0.4:0.4:0.3 | 0.038 | 1:1.0:0.4:0.1:0.4 | 0.045 | C/A | Extr | |
| 122 | gi/22001285 | Peroxidase 1 | 100 | 266 | 4 | 8.39/8.14 | 0:1.0:3.0:3.9:3.9 | 0.031 | 0:0:1.0:0.6:1.3 | 0.004 | B/B | Extr | |
| 123 | gi/22001285 | Peroxidase 1 | 100 | 136 | 6 | 8.42/8.14 | 0:0:1.0:0.6:0.8 | 0.029 | 0:0:1.0:0.8:1.6 | 0.026 | C/B | Extr | |
| 124 | gi/75246527 | Translationally-controlled tumor protein | 100 | 203 | 3 | 4.24/4.55 | 1:1.5:0.7:0.3:0.2 | 0.025 | 1:2.2:1.4:1.1:0.6 | 0.049 | C/C | Cyto | |
| 125 | gi/20257409 | Thaumatin-like protein | 100 | 255 | 6 | 7.65/7.85 | 0:0:0:1.0:6.7 | 0.024 | 0:0:1.0:2.3:2.0 | 0.030 | B/B | P | |
| 126 | gi/20257409 | Thaumatin-like protein | 100 | 162 | 2 | 7.80/7.85 | 0:0:0:1.0:8.9 | 0.016 | 0:0:1.0:1.3:0.9 | 0.034 | B/C | P | |
| 127 | gi/226897529 | Superoxide dismutase | 100 | 72 | 2 | 5.97/5.71 | - | - | 1.0:2.1:1.9:4.2:3.2 | 0.015 | -/C | Cyto | |
| 132 | gi/11990897 | Ribulose-1,5-bisphosphate carboxylase | 100 | 209 | 7 | 6.20/8.80 | 1.0:1.2:0.4:0.4:0.3 | 0.049 | 1:1.1:0.7:0.6:0.2 | 0.034 | A/C | P | |
| 140 | gi/34393258 | Putative Oxygen-evolving enhancer protein 3–1, | 99.83 | 59 | 1 | 9.45/9.82 | 1:0.6:0.5:0.4:0.4 | 0.018 | 1:0.7:0.6:0.4:0.4 | 0.031 | A/A | P | |
| 143 | gi/357152329 | Probable beta-D-xylosidase 7-like | 100 | 47 | 2 | 7.89/7.53 | 0:0:1.0:0.5:0.5 | 0.042 | 0:0:1.0:0.5:0.5 | 0.049 | C/C | P | |
| 146 | gi/2454602 | Barperm1 | 100 | 207 | 4 | 8.09/8.15 | 0:0:1.0:1.6:0.4 | 0.018 | 0:0:1.0:1.6:0.5 | 0.045 | C/C | P | |
| 147 | gi/115458852 | Os04g0465600 | 100 | 92 | 1 | 7.41/4.75 | 0:0:1.0:1.1:1.8 | 0.021 | 0:0:1.0:1.1:1.8 | 0.025 | B/B | Cyto | |
aSpot no: corresponds to protein spot on gels shown in Figure 2 and Figure 3.
bAccession no: predicted protein in NCBInr and UniprotKB database.
cProtein Score C.I.%: the PMF score percentage of protein sequence (Confidence interval: Protein Score C.I.% ≥ 95%).
dMP: Matched peptides.
eEpI/TpI: pI of protein on the gel/pI of predicted protein.
fHCP(J/Z): hierachical cluster pattern A-E (Jimai 20/Zhoumai 16).
gCyto: cytosol; P: plastid; Mito: mitochondria; ER: endoplasmic reticulum; Nucl: nuclear; Extr: extracellular.
Figure 4Distribution of the proteins identified during five grain development stages in Jimai 20 and Zhoumai 16. Nine protein groups were categorized based on putative functions.
Figure 5Protein isoforms and phosphoproteins identified by 2-DE and Pro-Q diamond staining. A total of 16 protein spots were identified as phosphoproteins, in which 5 spots (a-e) were newly identified phosphorylated proteins. Spot numbers correspond to those shown in Figure 2 and Figure 3 and Table 1.A: Spots from phase V of Jimai 20 stained with Coomassie Brilliant Blue (CBB stain). B: Spots from phase V of Jimai 20 stained with Pro-Q diamond phosphoprotein stain (Pro-Q stain). C: Gel images of proteins stained with Pro-Q Diamond at stage V by DryStrip (pH 3-10 L). Spots 122 and 123: Peroxidase 1 (gi/22001285); spots 112, 113 and 114: Class II chitinase (gi/62465514).
Phosphorylated proteins stained by Pro-Q Diamond and identified by MALDI-TOF/TOF-MS during grain filling
| 67* | gi/171027826 | Triticin | 100 | 84 | 100 | 6.43/64.90 | 8.79/30.52 | 2 | 18 | 2 | 4 |
| 70* | gi/215398470 | Globulin 3 | 100 | 471 | 100 | 7.78/66.31 | 7.58/63.57 | 6 | 17 | 6 | 2 |
| 94* | gi/38098487 | Alpha amylase inhibitor protein | 100 | 152 | 100 | 7.44/18.21 | 6.10/16.70 | 3 | 2 | 1 | 0 |
| 96* | gi/54778501 | 0.19 dimeric alpha-amylase inhibitor | 100 | 360 | 100 | 6.66/13.33 | 6.29/16.79 | 4 | | | |
| 100* | gi/225042 | Alpha amylase inhibitor | 100 | 259 | 100 | 6.77/19.62 | 6.87/20.32 | 4 | 8 | 2 | 3 |
| 102* | gi/54778507 | 0.19 dimeric alpha-amylase inhibitor | 100 | 373 | 100 | 5.73/13.24 | 6.07/15.90 | 4 | 2 | 0 | 2 |
| 112* | gi/62465514 | Class II chitinase | 100 | 95 | 100 | 8.66/28.20 | 8.81/30.60 | 2 | 9 | 3 | 1 |
| 113* | gi/62465514 | Class II chitinase | 100 | 69 | 99.38 | 8.66/28.20 | 9.23/30.23 | 1 | 9 | 3 | 1 |
| 114* | gi/62465514 | Class II chitinase | 100 | 138 | 100 | 8.66/28.20 | 8.52/30.56 | 2 | 9 | 3 | 1 |
| 122* | gi/22001285 | Peroxidase 1 | 100 | 138 | 100 | 8.14/38.80 | 8.55/51.53 | 4 | 11 | 5 | 2 |
| 123* | gi/22001285 | Peroxidase 1 | 100 | 206 | 100 | 8.14/38.80 | 8.22/51.66 | 4 | 11 | 5 | 2 |
| a# | gi/4558484 | Heat shock protein 101 | 100 | 288 | 100 | 5.95/101.06 | 5.20/90.65 | 6 | 21 | 3 | 7 |
| b# | gi/4204859 | Heat shock protein 80 | 100 | 286 | 100 | 5.00/80.33 | 3.29/83.11 | 5 | 24 | 9 | 6 |
| c# | gi/18146829 | Chitinase 3 | 100 | 63 | 100 | 6.89/33.46 | 8.42/31.12 | 1 | 10 | 6 | 4 |
| d# | gi/34925030 | RecName: Full = Wheatwin-1; AltName:Full = Pathogenesis-related protein 4a | 100 | 275 | 100 | 7.57/15.62 | 5.97/15.54 | 4 | 2 | 2 | 1 |
| e# | gi/34925032 | RecName: Full = Wheatwin-2; AltName:Full = Pathogenesis-related protein 4b | 100 | 224 | 100 | 8.18/15.86 | 6.88/15.63 | 4 | 2 | 2 | 1 |
Number of phosphorylation sites predicted by NetPhos 2.0 Server.
*Spot numbers correspond to those shown in Figure 2 and Figure 3.
#Newly identified phosphorylated protein spots.
Figure 6Hirerarchical clustering analysis of differentially accumulated protein spots in Jimai 20 (left) and Zhoumai 16 (right). Red color: the higher abundance of protein spots; blue color: the lower abundance of protein spots.
Figure 7Protein expression patterns in Jimai 20 and Zhoumai 16 during five grain developmental stages (A-E).
Figure 8Differential expression of six protein spots in Jimai 20 and Zhoumai 16 during five grain development stages. Spot 18 (II/III); spot 33 (II); spot 69 (II); spot 78 (V); spot 91 (I); spot 127 (IV).
Figure 9Transcriptional expression profiles of 10 representative protein genes from four grain development stages (I-IV) determined by qRT-PCR.
Details of grain samples harvested during the post-anthesis period based on thermal time corresponding to cumulative average daily temperatures
| I | 2011.05.04-05.10 | 6 | 147°C |
| II | 2011.05.10-05.15 | 11 | 252°C |
| III | 2011.05.15-05.19 | 15 | 353°C |
| IV | 2011.05.19-05.24 | 20 | 461°C |
| V | 2011.05.24-06.05 | 31 | 749°C |
*Days post-anthesis.